- Idec Pharmaceuticals Corp.
- Boehringer Ingelheim Fremont Inc.
- Rigel Pharmaceuticals Inc.
- deCODE genetics EHF
- Lexicon Pharmaceuticals Inc.
- Aerogen Ltd.
- Aralez Pharmaceuticals Inc.
- Adolor Corp.
- Array BioPharma Inc.
- Albany Molecular Research Inc.
- Novartis AG
- Scripps Research Institute
- Vertex Pharmaceuticals Inc.
- Idec nets $450.2mm in 2.6mm share FOPO
- Abgenix pulls in $231mm in private financing
- Rigel completes 5.65mm-share IPO
- DeCode goes public
- Lexicon Genetics completes $205mm IPO
- AeroGen nets $44.7mm in IPO
- Pozen closes $78.7mm IPO
- Adolor closes $95.6mm IPO
- Array BioPharma completes $51.2mm IPO
- Albany Molecular Research completes $46.5mm IPO
- Sandoz signs licensing agreement with Scripps Research Instit
- Novartis, Vertex in kinase protein deal
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.